» Articles » PMID: 36068807

Tumefactive Demyelination After Covid-19 Successfully Treated with Betainterferon 1A

Abstract

The Marburg variant of MS is a rare variant that leads to a severe clinical course, with a high rate of mortality or severe residual deficits and unclear pathophysiology. A 20-year-old female patient, presented at the hospital emergency with left inferior limb paresis and visual blurring. The neurologic exam showed complete and proportionate left hemiparesis with pyramidal signs and clonus, loss of proprioception and vibration in lower limbs, tactile, and painful hypoesthesia on the left side. This report describes a rare case of Marburg variant associated with COVID-19 infection.

References
1.
Oreja-Guevara C, Gomez-Pinedo U, Garcia-Lopez J, Sanchez-Sanchez R, Valverde-Moyano R, Rabano-Gutierrez A . Inhibition of neurogenesis in a case of Marburg variant multiple sclerosis. Mult Scler Relat Disord. 2017; 18:71-76. DOI: 10.1016/j.msard.2017.09.024. View

2.
Nozaki K, Abou-Fayssal N . High dose cyclophosphamide treatment in Marburg variant multiple sclerosis A case report. J Neurol Sci. 2010; 296(1-2):121-3. DOI: 10.1016/j.jns.2010.05.022. View

3.
Koska V, Forster M, Brouzou K, Hatami M, Arat E, Aytulun A . Case Report: Successful Stabilization of Marburg Variant Multiple Sclerosis With Ocrelizumab Following High-Dose Cyclophosphamide Rescue. Front Neurol. 2021; 12:696807. PMC: 8260950. DOI: 10.3389/fneur.2021.696807. View

4.
Suzuki M, Kawasaki H, Masaki K, Suzuki S, Terada T, Tsuchida T . An autopsy case of the Marburg variant of multiple sclerosis (acute multiple sclerosis). Intern Med. 2013; 52(16):1825-32. DOI: 10.2169/internalmedicine.52.0425. View

5.
Gupta K, Vasishta R, Kharbanda P, Vyas S, Prabhakar S . Marburg's disease: a diagnostic dilemma. Neurol Sci. 2011; 32(6):1195-201. DOI: 10.1007/s10072-011-0728-8. View